Edgen Stock·Oct 09 2025, 13:42戻る
戻る
Tempus AI Secures Major ARPA-H Contract for Precision Cancer Therapy Program
Edgen Stock·Oct 09 2025, 13:42
[1] Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy[2] Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy - Business Wire[3] CONTRACT to TEMPUS AI, INC | USAspending